D-peptide antagonist of PD-L1
D-peptide antagonist of PD-L1 has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 19, 2025: “Spatially Targeted PD-L1 Blockade for Restoring Exhausted Cytotoxic T Lymphocyte Rejuvenation to Potentiate Multimodal-Immune Synergistic Therapies for Breast Cancer Treatment”.
1 paper studies itUpdated